• Chart
  • F&O
  • Rating
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • News
  • FAQs
    1. Home
    2. Stocks
    3. Pel Share Price

    Piramal Enterprises Share PricePiramal Enterprises

    Mid Cap 8.1k Result
    ₹793.6
    6 (0.76%)
    As on 07 June, 2023 | 16:56 BSE: 500302 NSE: PEL
    Announcements Dividends

    Piramal Enterprises Performance

    Day Range

    • Low
    • High
    793.6

    52 Week Range

    • Low
    • High
    793.6
    • Open Price
    • Previous Close
    • Volume

    Start SIP in Piramal Enterprises

    Start SIP

    Piramal Enterprises Share Price

    • Over 1 Month 7.99%
    • Over 3 Month 1.71%
    • Over 6 Month -11.92%
    • Over 1 Year -55.8%

    Piramal Enterprises Key Statistics

    P/E Ratio 8.2
    PEG Ratio 0.4
    Market Cap Cr 18,940
    Price to Book Ratio 0.6
    EPS 101.4
    Dividend 4.2
    Relative Strength Index 67.18
    Money Flow Index 65.78
    MACD Signal 13.21
    Average True Range 16.78

    Piramal Enterprises F&O

    Piramal Enterprises Futures
    Piramal Enterprises Options

    Piramal Enterprises Investment Rating

    • Master Rating:

    • Piramal Enterprises has an operating revenue of Rs. 10,805.43 Cr. on a trailing 12-month basis. An annual revenue de-growth of -38% needs improvement, Pre-tax margin of 13% is healthy, ROE of 32% is exceptional. The company has a high debt to equity of 123%, which can be a reason to worry. The stock from a technical standpoint is trading below to its 200DMA and around 8% up from its 50DMA. It needs to take out the 200DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 42 which is a POOR score indicating inconsistency in earnings, a RS Rating of 24 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 110 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

    EPS Strength

    Price Strength

    Buyer Demand

    Group Rank

    Piramal Enterprises Financials
    IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
    Oper Rev Qtr Cr 1813,763455513574
    Operating Expenses Qtr Cr 31650971357341
    Operating Profit Qtr Cr 1503,113-516151232
    Depreciation Qtr Cr 28766
    Interest Qtr Cr 167165150156168
    Tax Qtr Cr 4658-150444
    Net Profit Qtr Cr -572,892-5128316

    Piramal Enterprises Technicals

    EMA & SMA

    Current Price
    ₹793.6
    6 (0.76%)
    • Bullish Moving Average
    • ___
    • 14
    • Bearish Moving Average
    • ___
    • 2
    • 20 Day
    • ₹765.44
    • 50 Day
    • ₹753
    • 100 Day
    • ₹789.48
    • 200 Day
    • ₹969.09
    • 20 Day
    • ₹761.87
    • 50 Day
    • ₹727.51
    • 100 Day
    • ₹766.66
    • 200 Day
    • ₹873.11

    Piramal Enterprises Resistance and Support

    PIVOT
    ₹788.55
    Resistance
    First Resistance ₹796.75
    Second Resistance ₹805.9
    Third Resistance ₹814.1
    RSI 67.19
    MFI 65.78
    MACD Single Line 13.21
    MACD 14.81
    Support
    First Resistance ₹779.4
    Second Resistance ₹771.2
    Third Resistance ₹762.05

    Piramal Enterprises Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 710,716 19,168,011 26.97
    Week 847,292 32,841,030 38.76
    1 Month 990,068 36,612,703 36.98
    6 Month 1,179,366 38,753,958 32.86

    Piramal Enterprises Result Highlights

    Piramal Enterprises Synopsis

    NSE-Medical-Diversified

    Piramal Enterprises is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 4785.22 Cr. and Equity Capital is Rs. 47.73 Cr. for the Year ended 31/03/2023. Piramal Enterprises Ltd. is a Public Limited Listed company incorporated on 26/04/1947 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24110MH1947PLC005719 and registration number is 005719.
    Market Cap 18,816
    Sales 4,912
    Shares in Float 13.60
    No of funds 278
    Yield 3.94
    Book Value 0.78
    U/D Vol ratio 1.2
    LTDebt / Equity 16
    Alpha -0.13
    Beta 1.55

    Piramal Enterprises

    Owner NameMar-23Dec-22Sep-22Jun-22
    Promoters 43.48%43.48%43.48%43.49%
    Mutual Funds 4.25%2.07%1.89%2.02%
    Insurance Companies 5.25%5.27%5.28%6.03%
    Foreign Portfolio Investors 28.67%31.25%32.05%34.54%
    Financial Institutions/ Banks 0.01%
    Individual Investors 13.17%12.33%11.71%9.29%
    Others 5.18%5.59%5.59%4.63%

    Piramal Enterprises Management

    Name Designation
    Mr. Ajay G Piramal Chairman
    Dr.(Mrs.) Swati A Piramal Vice Chairperson
    Ms. Nandini Piramal Executive Director
    Mr. Puneet Dalmia Independent Director
    Mr. Anand Piramal Non Executive Director
    Mr. Vijay Shah Non Executive Director
    Mr. Kunal Bahl Independent Director
    Mr. Khushru Jijina Executive Director
    Ms. Anjali Bansal Independent Director
    Mr. S Ramadorai Independent Director
    Mr. Shikha Sharma Independent Director
    Mr. N Vaghul Independent Director
    Mr. Suhail Nathani Independent Director
    Mr. Anita George Independent Director
    Mr. Rajiv Mehrishi Independent Director

    Piramal Enterprises Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Piramal Enterprises Corporate Action

    Date Purpose Remarks
    2023-05-05 Audited Results & Final Dividend
    2023-02-08 Quarterly Results
    2022-11-09 Quarterly Results
    2022-07-29 Quarterly Results
    2022-07-14 To consider raising of funds
    Date Purpose Remarks
    2023-06-16 FINAL Rs.31.00 per share(1550%)Final Dividend
    2022-07-15 FINAL Rs.33.00 per share(1650%)Final Dividend
    2021-07-07 FINAL Rs.33.00 per share(1650%)Final Dividend

    Piramal Enterprises MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 54413
    Kotak Equity Arbitrage Fund Growth 20587
    Nippon India Growth Fund - Growth 14143
    Nippon India Tax Saver (ELSS) Fund - Growth 11451
    ICICI Prudential Equity Arbitrage Fund Regular Growth 10189

    About Company

    Piramal Enterprises Limited is an Indian multinational pharmaceutical and financial services company based in Mumbai, Maharashtra. Founded by Ajay Piramal (who is also the Chairman), the company operates in the pharmaceuticals, financial services and real estate sector.

    He founded the company in 1984 after he acquired a small-scale manufacturing unit from his father. Today, Piramal has more than 50 offices across 30 countries and employs over 10,000 people worldwide. With a presence in 100+ countries through its subsidiaries or associate companies. Piramal has been ranked among Forbes Asia’s 200 Best Under A Billion in 2019.

    Business Verticals

    PEL's Global Pharma division has a strong product portfolio of niche differentiated branded generics that are difficult to manufacture, sell, or distribute. Through its worldwide network of facilities, PEL's Contract Development and Manufacturing Organisation (CDMO) services segment provide end-to-end solutions across the drug life cycle. 

    The Indian consumer products division of PEL serves India’s self-care market. PEL's OTC portfolio includes 21 major pharmaceutical and personal care brands in diverse product categories such as Vitamins & Nutrition, Dermatological & Antacids, Analgesics, and Baby Care. PEL's Healthcare Insights & Analytics division is the world's leading provider of healthcare analytics data, insight products and services to the world's leading pharma, biotech and medical technology companies, allowing them to make informed business decisions.

    PEL's financial services include wholesale lending, housing finance, and alternative asset management. Piramal Capital & Housing Finance Ltd, PEL's wholly-owned subsidiary, is registered as a housing finance company with National Housing Bank (NHB) and is involved in a variety of financial services businesses. It offers wholesale and retail funding opportunities across industries.

    Company History

    Piramal Enterprises was founded as Indian Schering Limited on April 26, 1947, by British Schering Ltd. With effect from September 27, 1979, the company's name was changed from Indian Schering Ltd to Nicholas Laboratories India Ltd. Gujarat Glass Ltd (GGL) was acquired with the company on April 1, 1990. The new formulation plant in Pithampur, Madhya Pradesh, was inaugurated in 1991. After a year, in 1992, the company established a second formulation plant in Pithampur, Madhya Pradesh, with cutting-edge manufacturing facilities. The company's name changed from 'Nicholas Laboratories Ltd' to 'Nicholas Piramal India Ltd' on December 2, 1992.
     

    Milestones

    1988
    Entered the pharmaceutical industry with the purchase of Nicholas Laboratories.
    A series of mergers and acquisitions, joint ventures and alliances, and organic initiatives.

    2010
    Over two decades, they built a leading Indian pharmaceutical company.
    The Domestic Formulations business was sold to Abbott in 2010 for USD 3.8 billion. Diagnostic Services were sold to Super Religare Laboratories.

    From 2020 onwards
    Multiple capital raise initiatives helped to strengthen the balance sheet.
    Through the sale of DRG and the exit of Shriram Transport, the organization structure was simplified.
    Subsidized the pharmaceutical businesses and raised new capital from Carlyle Transforming Financial Services with the DHFL acquisition to deliver long-term growth and profitability.
     

    Piramal Enterprises FAQs

    What is Share Price of Piramal Enterprises ?

    Piramal Enterprises share price is ₹793 As on 07 June, 2023 | 16:42

    What is the Market Cap of Piramal Enterprises ?

    The Market Cap of Piramal Enterprises is ₹18940.4 Cr As on 07 June, 2023 | 16:42

    What is the P/E ratio of Piramal Enterprises ?

    The P/E ratio of Piramal Enterprises is 8.2 As on 07 June, 2023 | 16:42

    What is the PB ratio of Piramal Enterprises ?

    The PB ratio of Piramal Enterprises is 0.6 As on 07 June, 2023 | 16:42

    What were the company's most recent reported sales and net income?

    Piramal Enterprises Ltd recorded net sales of INR 13993 crores in the year ending March 2022. 

    What is the future of the company's shares?

    Piramal Enterprises Ltd stock may be a good buy according to market analysts considering meaningful inroads into Retail led by mortgages and small-term loans via digital alliance.

    How to buy shares of Piramal Enterprises Ltd.?

    The company's shares can be bought online or offline by opening a Demat account with 5Paisa and verifying the KYC documents.

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support desk helpline: 8976689766

    Contact Us

    Enter Mobile Number

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from NSDL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
    ©2023, 5Paisa Capital Ltd. All Rights Reserved.
    We are ISO 27001:2013 Certified.

    Start Investing Now!

    Open Free Demat Account in 5 mins

    Enter Valid Mobile Number